While sEPO alone may not be sufficient as a screening tool for PV diagnosis, it still holds potential in the diagnostic algorithm, especially for patients who do not have a JAK2 mutation or facilities where the JAK2 mutation test is unavailable. The gene discussed is JAK2; the disease is acquired polycythemia vera.